Daviman Financial’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$395K Buy
15,681
+1,596
+11% +$40.2K 0.22% 60
2026
Q1
$356K Buy
14,085
+4,256
+43% +$109K 0.21% 59
2025
Q4
$251K Buy
+9,829
New +$252K 0.15% 77

Other funds holding IBDX

Daviman Financial's IBDX Position: Q2 2026 in Review

Daviman Financial increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 11% in Q2 2026, buying an estimated $40.2K and bringing the position to 15,681 shares worth $395K. The position accounts for 0.22% of the portfolio, ranked #60.

Daviman Financial first reported a position in IBDX in Q4 2025 and has held it in 3 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Daviman Financial held 15,681 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $395K as of Q2 2026.
  • Daviman Financial bought 1,596 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $40.2K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.22% of Daviman Financial's portfolio in Q2 2026, its #60 holding.
  • Daviman Financial first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2025 and has held it in 3 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Daviman Financial's 13F filing for Q2 2026, filed 27 Jul 2026.